Kalkulaator Bio Protocol kuni Euro
Muuda lihtsalt Bio Protocol Euro-ks meie kalkulaatoriga. Tutvu konversiooni arenguga ja peamiste vastavustega BIO ja EUR vahel.
Krüptovaluutade konverter
Bio Protocol - EUR — Turuandmed
Turu kapitalisatsioon
58,71 mln€
24h maht
25,58 mln€
Maksimaalne pakkumine
3,32 mld
Käibes olev pakkumine
3,32 mld
Tüüp
currency
Hind BIO/EUR - Bio Protocol/Euro
Bio Protocol hind on tõusnud
Bio Protocol väärtus on 0,0273€. See tähendab, et 5 BIO ostmiseks pead maksma 0,1366€. Vastupidi, 1,00€ abil saad osta kokku 36,58982803 BIO, samas kui 50,00€ võimaldaks sul soetada 1829,49140139 BIO.
Viimase 7 päeva jooksul on Bio Protocol hind kasvanud +10,88%. Samas, viimase 24 tunni jooksul on hind muutunud +8,19%.
BIO konversioon EUR
| Kogus | 12.06.2026, 02:13 |
|---|---|
| 0.5 BIO | 0,0137€ |
| 1 BIO | 0,0273€ |
| 2 BIO | 0,0547€ |
| 5 BIO | 0,1366€ |
| 10 BIO | 0,2733€ |
| 50 BIO | 1,37€ |
| 100 BIO | 2,73€ |
| 500 BIO | 13,67€ |
| 1000 BIO | 27,33€ |
EUR konversioon BIO
| Kogus | 12.06.2026, 02:13 |
|---|---|
| 0,5000€ | 0.01366500 BIO |
| 1,00€ | 0.02733000 BIO |
| 2,00€ | 0.05466000 BIO |
| 5,00€ | 0.13665000 BIO |
| 10,00€ | 0.27330000 BIO |
| 50,00€ | 1.36650000 BIO |
| 100,00€ | 2.73300000 BIO |
| 500,00€ | 13.66500000 BIO |
| 1.000,00€ | 27.33000000 BIO |
Osta Bio Protocol turvaliselt
Registreeru Bit2Me-s ja pääse kõige usaldusväärsemale krüptovaluutade vahetusplatvormile, et osta ja müüa Bio Protocol turvaliselt.
Mis on Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
